Sanofi SA (SASY)

Vienna
Currency in EUR
104.02
+0.76(+0.74%)
Closed

SASY Income Statement

Advanced Income Statement
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa37,36939,17545,38946,03344,286
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-0.7%+4.83%+15.86%+1.42%-3.8%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa12,10612,25113,69214,21613,205
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa25,26326,92431,69731,81731,081
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-1.53%+6.57%+17.73%+0.38%-2.31%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa67.6%68.73%69.83%69.12%70.18%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa17,68418,35920,65922,61521,619
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-6.2%+3.82%+12.53%+9.47%-4.4%
aa.aaaa.aaaa.aaaa.aaaa.aa5,5305,6926,7066,7287,394
aa.aaaa.aaaa.aaaa.aaaa.aa9,4489,59910,53910,7659,183
aa.aaaa.aaaa.aaaa.aaaa.aa1,0251,4881,5872,9503,293
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,5798,56511,0389,2029,462
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.42%+13.01%+28.87%-16.63%+2.83%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa20.28%21.86%24.32%19.99%21.37%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-422-359-22119-554
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+6.84%+14.93%+38.44%+108.6%-3,015.79%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-459-362-394-527-1,073
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa373173546519
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa497111101-78260
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa7,6548,31710,9188,4398,968
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa443418655688-
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-206-77255-578-575
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa14,1377,83710,4907,0386,997
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+370.14%-44.56%+33.85%-32.91%-0.58%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa37.83%20.01%23.11%15.29%15.8%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1,8071,5582,0061,6021,259
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa12,3306,2798,4845,4365,802
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-36-56-113-36-58
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa12,2946,2238,3715,4005,744
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+346.41%-49.38%+34.52%-35.49%+6.37%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa32.9%15.89%18.44%11.73%12.97%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa12,2946,2238,3715,4005,680
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.814.976.694.314.54
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+329.34%-49.34%+34.58%-35.48%+5.21%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9.764.956.664.34.54
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+329.96%-49.28%+34.55%-35.44%+5.56%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,253.61,252.51,251.91,251.71,251.4
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa1,260.11,257.91,256.91,256.41,251.4
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa3.23.333.563.763.92
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1.59%+4.06%+6.91%+5.62%+4.26%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa10,46611,25114,06212,52012,780
EBITDA Growth
aa.aaaa.aaaa.aa